Real-World Evaluation of the Economic Impact of Duration of Drug Therapy in the Treatment of Hepatitis C Virus (HCV)

被引:0
|
作者
McCombs, Jeffrey S.
Shin, Janet
Hines, Patricia
Saab, Sammy
Yuan, Yong
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S936 / S936
页数:1
相关论文
共 50 条
  • [31] Dual versus triple therapy in treatment of hepatitis C virus (HCV)
    Nevine Bishai
    Walid el Nabawy
    Mohamed El Fiki
    Mohamed Ibrahim
    Nouman El Garem
    Irish Journal of Medical Science (1971 -), 2023, 192 (3): : 1129 - 1135
  • [32] Dual versus triple therapy in treatment of hepatitis C virus (HCV)
    Bishai, Nevine
    El Nabawy, Walid
    El Fiki, Mohamed
    Ibrahim, Mohamed
    El Garem, Nouman
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (03) : 1129 - 1135
  • [33] The Impact of HIV Coinfection on Hepatitis C Virus (HCV) Treatment Initiation
    Henegar, Cassidy E.
    Beckerman, Robin
    Fusco, Jennifer
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 494 - 495
  • [34] Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study
    Martinez, Anthony
    Cheng, Wei-Han
    Marx, Steven E.
    Manthena, Shivaji
    Dylla, Douglas E.
    Wilson, Lauren
    Thomas, Emmanuel
    ADVANCES IN THERAPY, 2023, 40 (08) : 3465 - 3477
  • [35] Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study
    Anthony Martinez
    Wei-Han Cheng
    Steven E. Marx
    Shivaji Manthena
    Douglas E. Dylla
    Lauren Wilson
    Emmanuel Thomas
    Advances in Therapy, 2023, 40 : 3465 - 3477
  • [36] The Clinical and Economic Impact of Delayed Reperfusion Therapy: Real-World Evidence
    Gioppatto, Silvio
    Prado, Paulo Sousa
    Elias, Mariana Araujo Lima
    de Carvalho, Veronica Homem
    Paiva, Caio Resende da Costa
    Alexim, Gustavo de Almeida
    Reis, Ricardo Torres Bispo
    Nogueira, Ana Claudia Cavalcante
    Soares, Alexandre Anderson de Sousa Munhoz
    Nadruz, Wilson
    de Carvalho, Luiz Sergio F.
    Sposito, Andrei C.
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2024, 121 (05)
  • [37] Evaluation of Patient Preferences for Treatment Outcomes in Hepatitis C Virus (HCV)
    Lane, Suzanne
    Kirbach, Stephanie
    Gooch, Kathy
    Grinspan, Jessica
    Kallwitz, Eric R.
    Szabo, Shelagh M.
    Beusterien, Kathy
    HEPATOLOGY, 2012, 56 : 1025A - 1025A
  • [38] Hepatitis C Virus Treatment Response to Direct-acting Antivirals Among Adolescents With HIV/HCV Coinfection: Real-world Data From Ukraine
    Malik, Farihah
    Malyuta, Ruslan
    Volokha, Alla
    Bailey, Heather
    Collins, Intira Jeannie
    Thorne, Claire
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (05) : 417 - 419
  • [39] REAL-WORLD HEPATITIS C TREATMENT STRATEGIES IN THE UNITED KINGDOM AND DENMARK
    Jalbert, J.
    Lee, Y.
    Thiam, A.
    Bakshi, S.
    Weis, N.
    Hallager, S.
    McLauchlan, J.
    Irving, W.
    Amzal, B.
    VALUE IN HEALTH, 2016, 19 (03) : A221 - A222
  • [40] ADDRESSING BARRIERS TO HEPATITIS C VIRUS (HCV) ELIMINATION: REAL-WORLD OUTCOMES IN HISTORICALLY UNDERSERVED PATIENTS WITH CHRONIC HCV INFECTION TREATED WITH GLECAPREVIR/PIBRENTASVIR
    Lampertico, Pietro
    Peck-Radosavljevic, Markus
    Bondin, Mark I.
    Mazur, Wlodzimierz
    Magenta, Lorenzo
    Foucher, Juliette
    Porcalla, Ariel
    Crown, Eric D.
    Jalundhwala, Yash
    Zhang, Zhenzhen
    Mimidis, Konstantinos
    Hazzan, Rawi
    Marques, Nuno
    Bourgeois, Stefan
    HEPATOLOGY, 2019, 70 : 954A - 955A